The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Nilu Goonetilleke, Michael K P Liu, Jesus F Salazar-Gonzalez, Guido Ferrari, Elena Giorgi, Vitaly V Ganusov, Brandon F Keele, Gerald H Learn, Emma L Turnbull, Maria G Salazar, Kent J Weinhold, Stephen Moore, CHAVI Clinical Core B, Norman Letvin, Barton F Haynes, Myron S Cohen, Peter Hraber, Tanmoy Bhattacharya, Persephone Borrow, Alan S Perelson, Beatrice H Hahn, George M Shaw, Bette T Korber, Andrew J McMichael, Nilu Goonetilleke, Michael K P Liu, Jesus F Salazar-Gonzalez, Guido Ferrari, Elena Giorgi, Vitaly V Ganusov, Brandon F Keele, Gerald H Learn, Emma L Turnbull, Maria G Salazar, Kent J Weinhold, Stephen Moore, CHAVI Clinical Core B, Norman Letvin, Barton F Haynes, Myron S Cohen, Peter Hraber, Tanmoy Bhattacharya, Persephone Borrow, Alan S Perelson, Beatrice H Hahn, George M Shaw, Bette T Korber, Andrew J McMichael
Abstract
Identification of the transmitted/founder virus makes possible, for the first time, a genome-wide analysis of host immune responses against the infecting HIV-1 proteome. A complete dissection was made of the primary HIV-1-specific T cell response induced in three acutely infected patients. Cellular assays, together with new algorithms which identify sites of positive selection in the virus genome, showed that primary HIV-1-specific T cells rapidly select escape mutations concurrent with falling virus load in acute infection. Kinetic analysis and mathematical modeling of virus immune escape showed that the contribution of CD8 T cell-mediated killing of productively infected cells was earlier and much greater than previously recognized and that it contributed to the initial decline of plasma virus in acute infection. After virus escape, these first T cell responses often rapidly waned, leaving or being succeeded by T cell responses to epitopes which escaped more slowly or were invariant. These latter responses are likely to be important in maintaining the already established virus set point. In addition to mutations selected by T cells, there were other selected regions that accrued mutations more gradually but were not associated with a T cell response. These included clusters of mutations in envelope that were targeted by NAbs, a few isolated sites that reverted to the consensus sequence, and bystander mutations in linkage with T cell-driven escape.
Figures
References
- Gasper-Smith N., Crossman D.M., Whitesides J.F., Mensali N., Ottinger J.S., Plonk S.G., Moody M.A., Ferrari G., Weinhold K.J., Miller S.E., et al. 2008. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.J. Virol. 82:7700–7710
- Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., Douek D.C. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.J. Exp. Med. 200:749–759
- Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., Heldebrant C., Smith R., Conrad A., Kleinman S.H., Busch M.P. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.AIDS. 17:1871–1879
- Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., et al. 2007. A whole-genome association study of major determinants for host control of HIV-1.Science. 317:944–947
- Ho D.D. 1996. Viral counts count in HIV infection.Science. 272:1124–1125
- Phillips A.N. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response.Science. 271:497–499
- Davenport M.P., Ribeiro R.M., Zhang L., Wilson D.P., Perelson A.S. 2007. Understanding the mechanisms and limitations of immune control of HIV.Immunol. Rev. 216:164–175
- Petravic J., Loh L., Kent S.J., Davenport M.P. 2008. CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo.J. Virol. 82:4091–4101
- Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., Dandekar S. 2003. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.J. Virol. 77:11708–11717
- Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., et al. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.Science. 283:857–860
- Borrow P., Lewicki H., Hahn B.H., Shaw G.M., Oldstone M.B. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.J. Virol. 68:6103–6110
- Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., Ho D.D. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.J. Virol. 68:4650–4655
- Wilson J.D., Ogg G.S., Allen R.L., Davis C., Shaunak S., Downie J., Dyer W., Workman C., Sullivan S., McMichael A., Rowland-Jones S.L. 2000. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.AIDS. 14:225–233
- Huber M., Trkola A. 2007. Humoral immunity to HIV-1: neutralization and beyond.J. Intern. Med. 262:5–25
- Carrington M., O'Brien S.J. 2003. The influence of HLA genotype on AIDS.Annu. Rev. Med. 54:535–551
- Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B., Shaw G.M. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.Nat. Med. 3:205–211
- Liu Y., McNevin J., Cao J., Zhao H., Genowati I., Wong K., McLaughlin S., McSweyn M.D., Diem K., Stevens C.E., et al. 2006. Selection on the human immunodeficiency virus type 1 proteome following primary infection.J. Virol. 80:9519–9529
- Kelleher A.D., Long C., Holmes E.C., Allen R.L., Wilson J., Conlon C., Workman C., Shaunak S., Olson K., Goulder P., et al. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.J. Exp. Med. 193:375–386
- Price D.A., Goulder P.J., Klenerman P., Sewell A.K., Easterbrook P.J., Troop M., Bangham C.R., Phillips R.E. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.Proc. Natl. Acad. Sci. USA. 94:1890–1895
- Allen T.M., Altfeld M., Geer S.C., Kalife E.T., Moore C., O'Sullivan K.M., Desouza I., Feeney M.E., Eldridge R.L., Maier E.L., Kaufmann D.E., Lahaie M.P., Reyor L., Tanzi G., Johnston M.N., Brander C., Draenert R., Rockstroh J.K., Jessen H., Rosenberg E.S., Mallal S.A., Walker B.D. 2005. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.J. Virol. 79:13239–13249
- Jones N.A., Wei X., Flower D.R., Wong M., Michor F., Saag M.S., Hahn B.H., Nowak M.A., Shaw G.M., Borrow P. 2004. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.J. Exp. Med. 200:1243–1256
- Cao J., McNevin J., Malhotra U., McElrath M.J. 2003. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.J. Immunol. 171:3837–3846
- Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission.Nat. Med. 10:282–289
- Brumme Z.L., Brumme C.J., Carlson J., Streeck H., John M., Eichbaum Q., Block B.L., Baker B., Kadie C., Markowitz M., et al. 2008. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.J. Virol. 82:9216–9227
- Koup R.A. 1994. Virus escape from CTL recognition.J. Exp. Med. 180:779–782
- Crawford H., Prado J.G., Leslie A., Hue S., Honeyborne I., Reddy S., van der Stok M., Mncube Z., Brander C., Rousseau C., et al. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.J. Virol. 81:8346–8351
- Bhattacharya T., Daniels M., Heckerman D., Foley B., Frahm N., Kadie C., Carlson J., Yusim K., McMahon B., Gaschen B., et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.Science. 315:1583–1586
- Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.Proc. Natl. Acad. Sci. USA. 105:7552–7557
- Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Jr., Giorgi E.E., Hiu L., Decker J.M., Wang S., Baalwa J., Kraus M.H., et al. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.J. Exp. Med. 206:1273–1289
- Altfeld M., Addo M.M., Shankarappa R., Lee P.K., Allen T.M., Yu X.G., Rathod A., Harlow J., O'Sullivan K., Johnston M.N., et al. 2003. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.J. Virol. 77:7330–7340
- Pilcher C.D., Fiscus S.A., Nguyen T.Q., Foust E., Wolf L., Williams D., Ashby R., O'Dowd J.O., McPherson J.T., Stalzer B., et al. 2005. Detection of acute infections during HIV testing in North Carolina.N. Engl. J. Med. 352:1873–1883
- Valentine L.E., Piaskowski S.M., Rakasz E.G., Henry N.L., Wilson N.A., Watkins D.I. 2008. Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.J. Virol. 82:575–581
- Goonetilleke N., Moore S., Dally L., Winstone N., Cebere I., Mahmoud A., Pinheiro S., Gillespie G., Brown D., Loach V., et al. 2006. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.J. Virol. 80:4717–4728
- Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M., et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.J. Exp. Med. 199:905–915
- Asquith B., Edwards C.T., Lipsitch M., McLean A.R. 2006. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo.PLoS Biol. 4:e90.
- Markowitz M., Louie M., Hurley A., Sun E., Di Mascio M., Perelson A.S., Ho D.D. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.J. Virol. 77:5037–5038
- Bernardin F., Kong D., Peddada L., Baxter-Lowe L.A., Delwart E. 2005. Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes.J. Virol. 79:11523–11528
- Friedrich T.C., Dodds E.J., Yant L.J., Vojnov L., Rudersdorf R., Cullen C., Evans D.T., Desrosiers R.C., Mothe B.R., Sidney J., et al. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo.Nat. Med. 10:275–281
- Loh L., Petravic J., Batten C.J., Davenport M.P., Kent S.J. 2008. Vaccination and timing influence SIV immune escape viral dynamics in vivo.PLoS Pathog. 4:e12.
- Li B., Gladden A.D., Altfeld M., Kaldor J.M., Cooper D.A., Kelleher A.D., Allen T.M. 2007. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.J. Virol. 81:193–201
- Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.J. Virol. 80:3617–3623
- Schneidewind A., Brockman M.A., Yang R., Adam R.I., Li B., Le Gall S., Rinaldo C.R., Craggs S.L., Allgaier R.L., Power K.A., et al. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.J. Virol. 81:12382–12393
- Casazza J.P., Betts M.R., Picker L.J., Koup R.A. 2001. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.J. Virol. 75:6508–6516
- McCune J.M., Hanley M.B., Cesar D., Halvorsen R., Hoh R., Schmidt D., Wieder E., Deeks S., Siler S., Neese R., Hellerstein M. 2000. Factors influencing T-cell turnover in HIV-1-seropositive patients.J. Clin. Invest. 105:R1–R8
- Sun J.C., Williams M.A., Bevan M.J. 2004. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.Nat. Immunol. 5:927–933
- Nowak M.A., Bonhoeffer S., Shaw G.M., May R.M. 1997. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations.J. Theor. Biol. 184:203–217
- Harcourt G.C., Garrard S., Davenport M.P., Edwards A., Phillips R.E. 1998. HIV-1 variation diminishes CD4 T lymphocyte recognition.J. Exp. Med. 188:1785–1793
- Chung A.W., Rollman E., Center R.J., Kent S.J., Stratov I. 2009. Rapid degranulation of NK cells following activation by HIV-specific antibodies.J. Immunol. 182:1202–1210
- Hansasuta P., Dong T., Thananchai H., Weekes M., Willberg C., Aldemir H., Rowland-Jones S., Braud V.M. 2004. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.Eur. J. Immunol. 34:1673–1679
- Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N., Yawata M., Easterbrook P., McVicar D.W., Maenaka K., Parham P., et al. 2007. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.J. Immunol. 178:33–37
- Lichterfeld M., Kavanagh D.G., Williams K.L., Moza B., Mui S.K., Miura T., Sivamurthy R., Allgaier R., Pereyra F., Trocha A., et al. 2007. A viral CTL escape mutation leading to immunoglobulin-like transcript 4–mediated functional inhibition of myelomonocytic cells.J. Exp. Med. 204:2813–2824
- Allen T.M., O'Connor D.H., Jing P., Dzuris J.L., Mothe B.R., Vogel T.U., Dunphy E., Liebl M.E., Emerson C., Wilson N., et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.Nature. 407:386–390
- O'Connor D.H., Allen T.M., Vogel T.U., Jing P., DeSouza I.P., Dodds E., Dunphy E.J., Melsaether C., Mothe B., Yamamoto H., et al. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.Nat. Med. 8:493–499
- Kuroda M.J., Schmitz J.E., Charini W.A., Nickerson C.E., Lord C.I., Forman M.A., Letvin N.L. 1999. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.J. Virol. 73:1573–1579
- Liu J., O'Brien K.L., Lynch D.M., Simmons N.L., La Porte A., Riggs A.M., Abbink P., Coffey R.T., Grandpre L.E., Seaman M.S., et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.Nature. 457:87–91
- Bunce M. 2003. PCR-sequence-specific primer typing of HLA class I and class II alleles.Methods Mol. Biol. 210:143–171
- Roederer M., Koup R.A. 2003. Optimized determination of T cell epitope responses.J. Immunol. Methods. 274:221–228
- Storey J.D., Tibshirani R. 2003. Statistical significance for genomewide studies.Proc. Natl. Acad. Sci. USA. 100:9440–9445
- Pond S.L., Frost S.D. 2005. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.Bioinformatics. 21:2531–2533
- Kosakovsky Pond S.L., Frost S.D. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection.Mol. Biol. Evol. 22:1208–1222
- Kosakovsky Pond S.L., Posada D., Gravenor M.B., Woelk C.H., Frost S.D. 2006. GARD: a genetic algorithm for recombination detection.Bioinformatics. 22:3096–3098
- Ganusov V.V., De Boer R.J. 2006. Estimating costs and benefits of CTL escape mutations in SIV/HIV Infection.PLOS Comput. Biol. 2:e24.
- Maness N.J., Valentine L.E., May G.E., Reed J., Piaskowski S.M., Soma T., Furlott J., Rakasz E.G., Friedrich T.C., Price D.A., et al. 2007. AIDS virus–specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape.J. Exp. Med. 204:2505–2512
Source: PubMed